Drug profile · INN
covid-19 (sars-cov-2) vaccine (recombinant chimpanzee adenovirus vector)
VAXZEVRIA (NOTE 2)
- Patents linked
- 0
- News articles
- 0
Quick answer
covid-19 (sars-cov-2) vaccine (recombinant chimpanzee adenovirus vector) (VAXZEVRIA (NOTE 2)) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN covid-19 (sars-cov-2) vaccine (recombinant chimpanzee adenovirus vector)
Brand VAXZEVRIA (NOTE 2)
Frequently asked questions
What is covid-19 (sars-cov-2) vaccine (recombinant chimpanzee adenovirus vector)?
covid-19 (sars-cov-2) vaccine (recombinant chimpanzee adenovirus vector) (VAXZEVRIA (NOTE 2)) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for covid-19 (sars-cov-2) vaccine (recombinant chimpanzee adenovirus vector)?
VAXZEVRIA (NOTE 2) is a marketed brand name for covid-19 (sars-cov-2) vaccine (recombinant chimpanzee adenovirus vector). Check FDA Drugs@FDA for the current US label holder and prescribing information.